List of Tables
Table 1. Global Market Pulmonary Arterial Hypertension Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Pulmonary Arterial Hypertension Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Pulmonary Arterial Hypertension Treatment Market Size Share by Region (2018-2023)
Table 4. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Pulmonary Arterial Hypertension Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Pulmonary Arterial Hypertension Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2024-2029)
Table 11. North America Pulmonary Arterial Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Pulmonary Arterial Hypertension Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Pulmonary Arterial Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Pulmonary Arterial Hypertension Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Pulmonary Arterial Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Pulmonary Arterial Hypertension Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Pulmonary Arterial Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Pulmonary Arterial Hypertension Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Pulmonary Arterial Hypertension Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Pulmonary Arterial Hypertension Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Pulmonary Arterial Hypertension Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Pulmonary Arterial Hypertension Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2018-2023)
Table 24. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2024-2029)
Table 26. North America Pulmonary Arterial Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Pulmonary Arterial Hypertension Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Pulmonary Arterial Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Pulmonary Arterial Hypertension Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Pulmonary Arterial Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Pulmonary Arterial Hypertension Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Pulmonary Arterial Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Pulmonary Arterial Hypertension Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Pulmonary Arterial Hypertension Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Pulmonary Arterial Hypertension Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Pulmonary Arterial Hypertension Treatment Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pulmonary Arterial Hypertension Treatment as of 2022)
Table 39. Date of Key Players Enter into Pulmonary Arterial Hypertension Treatment Market
Table 40. Global Pulmonary Arterial Hypertension Treatment Key Players Headquarters and Area Served
Table 41. Pulmonary Arterial Hypertension Treatment Product Solution and Service
Table 42. Global Pulmonary Arterial Hypertension Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. GSK Basic Information List
Table 45. GSK Description and Business Overview
Table 46. GSK Pulmonary Arterial Hypertension Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Pulmonary Arterial Hypertension Treatment Business of GSK (2018-2023)
Table 48. GSK Recent Developments
Table 49. Eli Lilly and Company Basic Information List
Table 50. Eli Lilly and Company Description and Business Overview
Table 51. Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Pulmonary Arterial Hypertension Treatment Business of Eli Lilly and Company (2018-2023)
Table 53. Eli Lilly and Company Recent Developments
Table 54. Pfizer Inc Basic Information List
Table 55. Pfizer Inc Description and Business Overview
Table 56. Pfizer Inc Pulmonary Arterial Hypertension Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Pulmonary Arterial Hypertension Treatment Business of Pfizer Inc (2018-2023)
Table 58. Pfizer Inc Recent Developments
Table 59. Actelion Inc Basic Information List
Table 60. Actelion Inc Description and Business Overview
Table 61. Actelion Inc Pulmonary Arterial Hypertension Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Pulmonary Arterial Hypertension Treatment Business of Actelion Inc (2018-2023)
Table 63. Actelion Inc Recent Developments
Table 64. United Therapeutic Corporation Basic Information List
Table 65. United Therapeutic Corporation Description and Business Overview
Table 66. United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Pulmonary Arterial Hypertension Treatment Business of United Therapeutic Corporation (2018-2023)
Table 68. United Therapeutic Corporation Recent Developments
Table 69. SteadyMed Ltd Basic Information List
Table 70. SteadyMed Ltd Description and Business Overview
Table 71. SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Pulmonary Arterial Hypertension Treatment Business of SteadyMed Ltd (2018-2023)
Table 73. SteadyMed Ltd Recent Developments
Table 74. Gilead Sciences, Inc Basic Information List
Table 75. Gilead Sciences, Inc Description and Business Overview
Table 76. Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Pulmonary Arterial Hypertension Treatment Business of Gilead Sciences, Inc (2018-2023)
Table 78. Gilead Sciences, Inc Recent Developments
Table 79. Teva Pharmaceuticals Inc Basic Information List
Table 80. Teva Pharmaceuticals Inc Description and Business Overview
Table 81. Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Pulmonary Arterial Hypertension Treatment Business of Teva Pharmaceuticals Inc (2018-2023)
Table 83. Teva Pharmaceuticals Inc Recent Developments
Table 84. Bayer AG Basic Information List
Table 85. Bayer AG Description and Business Overview
Table 86. Bayer AG Pulmonary Arterial Hypertension Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Pulmonary Arterial Hypertension Treatment Business of Bayer AG (2018-2023)
Table 88. Bayer AG Recent Developments
Table 89. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 90. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 91. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 92. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 94. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 95. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 96. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Region (2018-2023)
Table 97. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Region (2024-2029)
Table 98. Latin America Pulmonary Arterial Hypertension Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 100. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 101. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 102. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 103. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 104. Pulmonary Arterial Hypertension Treatment Market Trends
Table 105. Pulmonary Arterial Hypertension Treatment Market Drivers
Table 106. Pulmonary Arterial Hypertension Treatment Market Challenges
Table 107. Pulmonary Arterial Hypertension Treatment Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary Arterial Hypertension Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Pulmonary Arterial Hypertension Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Pulmonary Arterial Hypertension Treatment Market Share by Regions: 2022 VS 2029
Figure 4. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Pulmonary Arterial Hypertension Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Pulmonary Arterial Hypertension Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Pulmonary Arterial Hypertension Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Vasodilators
Figure 11. Global Vasodilators Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Phosphodiesterase 5 (PDE 5) Inhibitors
Figure 13. Global Phosphodiesterase 5 (PDE 5) Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Endothelin Receptor Antagonists (ERA)
Figure 15. Global Endothelin Receptor Antagonists (ERA) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Soluble Guanylate Cyclase (SGC) Stimulator
Figure 17. Global Soluble Guanylate Cyclase (SGC) Stimulator Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Global Pulmonary Arterial Hypertension Treatment Market Size Share by Type: 2022 & 2029
Figure 19. North America Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2018-2029)
Figure 20. Europe Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2018-2029)
Figure 21. Asia-Pacific Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2018-2029)
Figure 22. Latin America Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2018-2029)
Figure 23. Middle East and Africa Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2018-2029)
Figure 24. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Online Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Global Pulmonary Arterial Hypertension Treatment Market Size Share by Application: 2022 & 2029
Figure 28. North America Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2018-2029)
Figure 29. Europe Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2018-2029)
Figure 30. Asia-Pacific Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2018-2029)
Figure 31. Latin America Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2018-2029)
Figure 32. Middle East and Africa Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2018-2029)
Figure 33. Pulmonary Arterial Hypertension Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Pulmonary Arterial Hypertension Treatment Market Share in 2022
Figure 35. North America Pulmonary Arterial Hypertension Treatment Market Share by Country (2018-2029)
Figure 36. United States Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 37. Canada Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 38. Germany Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 39. France Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 40. U.K. Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 41. Italy Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 42. Russia Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 43. Nordic Countries Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 44. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Region (2018-2029)
Figure 45. China Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 46. Japan Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 47. South Korea Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 48. Southeast Asia Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 49. India Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 50. Australia Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 51. Latin America Pulmonary Arterial Hypertension Treatment Market Share by Country (2018-2029)
Figure 52. Mexico Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 53. Brazil Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Country (2018-2029)
Figure 55. Turkey Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 57. UAE Pulmonary Arterial Hypertension Treatment Market Size (2018-2029) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report
